179 related articles for article (PubMed ID: 26622704)
1. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.
Li X; Guo F; Liu Y; Chen HJ; Wen F; Zou B; Li D; Qin Q; Liu X; Shen Y; Wang Y
Oncol Lett; 2015 Sep; 10(3):1533-1540. PubMed ID: 26622704
[TBL] [Abstract][Full Text] [Related]
2. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
3. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
Zhan L; Zhang J; Zhang J; Liu X; Zhu S; Shi Y; He Y; Wang W; Fan Y; Tang Z; Chen G; Wei B; Cao Y
Cancer Lett; 2022 Mar; 529():37-52. PubMed ID: 34974132
[TBL] [Abstract][Full Text] [Related]
4. NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
Yoshihama S; Vijayan S; Sidiq T; Kobayashi KS
Trends Cancer; 2017 Jan; 3(1):28-38. PubMed ID: 28718425
[TBL] [Abstract][Full Text] [Related]
5. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.
Vijayan S; Sidiq T; Yousuf S; van den Elsen PJ; Kobayashi KS
Immunogenetics; 2019 Mar; 71(3):273-282. PubMed ID: 30706093
[TBL] [Abstract][Full Text] [Related]
6. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
Chelbi ST; Dang AT; Guarda G
Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
[TBL] [Abstract][Full Text] [Related]
7. BMI1 induces ubiquitination and protein degradation of Nod-like receptor family CARD domain containing 5 and suppresses human leukocyte antigen class I expression to induce immune escape in non-small cell lung cancer.
Lu ZH; Tu GJ; Fu SL; Shang K; Peng SJ; Chen L; Gu XJ
Kaohsiung J Med Sci; 2022 Dec; 38(12):1190-1202. PubMed ID: 36194200
[TBL] [Abstract][Full Text] [Related]
8. MHC class I transactivator NLRC5 in host immunity, cancer and beyond.
Cho SX; Vijayan S; Yoo JS; Watanabe T; Ouda R; An N; Kobayashi KS
Immunology; 2021 Mar; 162(3):252-261. PubMed ID: 32633419
[TBL] [Abstract][Full Text] [Related]
9. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
10. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
[TBL] [Abstract][Full Text] [Related]
11. MHC class II expression in lung cancer.
He Y; Rozeboom L; Rivard CJ; Ellison K; Dziadziuszko R; Yu H; Zhou C; Hirsch FR
Lung Cancer; 2017 Oct; 112():75-80. PubMed ID: 29191604
[TBL] [Abstract][Full Text] [Related]
12. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
[TBL] [Abstract][Full Text] [Related]
13. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
[TBL] [Abstract][Full Text] [Related]
14. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
Neerincx A; Rodriguez GM; Steimle V; Kufer TA
J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
[TBL] [Abstract][Full Text] [Related]
15. NLRC5 deficiency has a moderate impact on immunodominant CD8
Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
[TBL] [Abstract][Full Text] [Related]
16. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
Rodriguez GM; Yakubovich E; Murshed H; Maranda V; Galpin KJC; Cudmore A; Hanna AMR; Macdonald E; Ramesh S; Garson K; Vanderhyden BC
Front Immunol; 2023; 14():1295208. PubMed ID: 38235131
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation.
Lian L; Ciraci C; Chang G; Hu J; Lamont SJ
BMC Vet Res; 2012 Mar; 8():23. PubMed ID: 22401171
[TBL] [Abstract][Full Text] [Related]
18. Neuronal NLRC5 regulates MHC class I expression in Neuro-2a cells and also during hippocampal development.
Li P; Shen Y; Cui P; Hu Y; Zhang Y; Miao F; Zhang A; Zhang J
J Neurochem; 2020 Jan; 152(2):182-194. PubMed ID: 31549732
[TBL] [Abstract][Full Text] [Related]
19. Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.
Zhao MZ; Sun Y; Jiang XF; Liu L; Liu L; Sun LX
Immunol Res; 2019 Dec; 67(6):497-504. PubMed ID: 31900803
[TBL] [Abstract][Full Text] [Related]
20. Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer.
Zhan L; Zhang J; Wei B; Cao Y
Autophagy; 2022 Apr; 18(4):942-943. PubMed ID: 35174769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
